PassPort Technologies, Inc. Announces Positive Interim Phase I Results of Zolmitriptan Transdermal Microporation System for the Treatment of Acute Migraine | BioSpace Source Cluster: BioSpace Source Node: 2530006Time Stamp: Mar 28, 2024
IGC Pharma Reports Third Quarter Fiscal 2024 Results Source Cluster: Fintech News Source Node: 2484875Time Stamp: Feb 16, 2024
Maui Grown Remedies Gives Away 10,000 High Performance CBD Products to Source Cluster: MGRetailer Source Node: 2482271Time Stamp: Feb 15, 2024